Status:
COMPLETED
National Registry of Liver First Approach
Lead Sponsor:
Hospital Miguel Servet
Collaborating Sponsors:
Spanish Association of Surgeons (AEC)
Conditions:
Colonic Cancer
Rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Liver metastases are present in 15-25% of patients with colorectal cancer at the time of diagnosis of the primary tumor, which is defined as synchronous liver metastases. Treatment for the potential c...
Detailed Description
Liver metastases are present in 15-25% of patients with colorectal cancer at the time of diagnosis of the primary tumor, which is defined as synchronous liver metastases. Treatment for the potential c...
Eligibility Criteria
Inclusion
- Patients ≥ 18 year old.
- Scheduled surgery for colorectal cancer with synchronous liver metastases using the liver first approach.
- ASA score I-III.
- They have signed the informed consent.
Exclusion
- Patients under 18 year old.
- ASA ≥ IV.
- Urgent surgery.
- Patients who have not signed the informed consent.
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT04683783
Start Date
June 1 2019
End Date
November 30 2020
Last Update
December 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mario Serradilla Martín
Zaragoza, Spain, 50008